Newbridge Financial Services Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.8K Hold
300
0.01% 427
2026
Q1
$55K Hold
300
0.01% 406
2025
Q4
$52.8K Hold
300
0.01% 419
2025
Q3
$42K Hold
300
0.01% 552
2025
Q2
$37.7K Hold
300
0.01% 565
2025
Q1
$41.1K Hold
300
0.01% 407
2024
Q4
$45.9K Hold
300
0.01% 424
2024
Q3
$58.2K Hold
300
0.02% 238
2024
Q2
$69.5K Sell
300
-111
-27% -$24.1K 0.03% 318
2024
Q1
$88.6K Buy
+411
New +$96.3K 0.04% 307
2023
Q4
Sell
-500
Closed -$129K 1175
2023
Q3
$129K Sell
500
-200
-29% -$53.5K 0.06% 248
2023
Q2
$199K Hold
700
0.1% 202
2023
Q1
$195K Hold
700
0.1% 196
2022
Q4
$194K Hold
700
0.11% 183
2022
Q3
$187K Sell
700
-26
-4% -$5.52K 0.11% 197
2022
Q2
$148K Sell
726
-320
-31% -$65.4K 0.09% 205
2022
Q1
$220K Hold
1,046
0.11% 181
2021
Q4
$251K Buy
1,046
+250
+31% +$64.3K 0.12% 174
2021
Q3
$225K Hold
796
0.14% 159
2021
Q2
$276K Hold
796
0.17% 133
2021
Q1
$223K Sell
796
-24
-3% -$6.47K 0.16% 144
2020
Q4
$201K Sell
820
-78
-9% -$20.1K 0.17% 136
2020
Q3
$255K Buy
+898
New +$250K 0.25% 90

Other funds holding BIIB

Newbridge Financial Services Group's BIIB Position: Q2 2026 in Review

Newbridge Financial Services Group held its Biogen (BIIB) position steady in Q2 2026 at 300 shares worth $64.8K. The position accounts for 0.01% of the portfolio, ranked #427.

Newbridge Financial Services Group first reported a position in BIIB in Q3 2020 and has held it in 23 quarters since. The position peaked at $276K in Q2 2021. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Newbridge Financial Services Group held 300 shares of Biogen worth $64.8K as of Q2 2026.
  • Newbridge Financial Services Group left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #427 holding.
  • Newbridge Financial Services Group first reported a position in Biogen in Q3 2020 and has held it in 23 quarters since.
  • Newbridge Financial Services Group's Biogen position peaked at $276K in Q2 2021.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.